SCOPUS 정보 검색 플랫폼

Journal of Clinical Pathology

Volumn 62, Issue 4, 2009, Pages 373-376

Hormone-sensitive prostate cancer: A case of ETS gene fusion heterogeneity

(8) Attard, G a,b Jameson, C a Moreira, J a,b Flohr, P b Parker, C a,b Dearnaley, D a,b Cooper, C S b De Bono, J S a,b

a INSTITUTE OF CANCER RESEARCH (United Kingdom)

b INSTITUTE OF CANCER RESEARCH (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABIRATERONE ACETATE; BICALUTAMIDE; DEXAMETHASONE; DIETHYLSTILBESTROL; GONADORELIN AGONIST; PHOSPHOTRANSFERASE INHIBITOR; PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR ERG; UNCLASSIFIED DRUG; ZK 304709; ZOLEDRONIC ACID;

ADULT; ARTICLE; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CHROMOSOME REARRANGEMENT; GENE DUPLICATION; GENE FUSION; GENE LOCUS; GENE SEQUENCE; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL;

ANTINEOPLASTIC AGENTS, HORMONAL; DNA-BINDING PROTEINS; GENE FUSION; HUMANS; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-ETS; RETROSPECTIVE STUDIES; TRANSCRIPTION FACTORS;

EID: 65849327990 PISSN: 00219746 EISSN: 14724146 Source Type: Journal
DOI: 10.1136/jcp.2008.061515 Document Type: Article

Times cited : (22)

References (10)

1
- 41349099104
- Cancer statistics
- Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96. (Pubitemid 20002311)
- (2008) Ca-A Cancer Journal for Clinicians , vol.58 , pp. 71-96
- Jemal, A.¹ Siegel, R.² Ward, E.³

2
- 33847638137
- Estimates of the cancer incidence and mortality in Europe in 2006
- DOI 10.1093/annonc/mdl498
- Ferlay J, Autier P, Boniol M, et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-592 (Pubitemid 46359643)
- (2007) Annals of Oncology , vol.18 , Issue.3 , pp. 581-592
- Ferlay, J.¹ Autier, P.² Boniol, M.³ Heanue, M.⁴ Colombet, M.⁵ Boyle, P.⁶

3
- 0036112592
- The current state of hormonal therapy for prostate cancer
- Hellerstedt BA, Pienta KJ. The current state of hormonal therapy for prostate cancer. CA Cancer J Clin 2002;52:154-179 (Pubitemid 34546107)
- (2002) Ca-A Cancer Journal for Clinicians , vol.52 , Issue.3 , pp. 154-179
- Hellerstedt, B.A.¹ Pienta, K.J.²

4
- 27344451557
- Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
- DOI 10.1126/science.1117679
- Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005;310(5748):644- 648 (Pubitemid 41528150)
- (2005) Science , vol.310 , Issue.5748 , pp. 644-648
- Tomlins, S.A.¹ Rhodes, D.R.² Perner, S.³ Dhanasekaran, S.M.⁴ Mehra, R.⁵ Sun, X.-W.⁶ Varambally, S.⁷ Cao, X.⁸ Tchinda, J.⁹ Kuefer, R.¹⁰ Lee, C.¹¹ Montie, J.E.¹² Shah, R.B.¹³ Pienta, K.J.¹⁴ Rubin, M.A.¹⁵ Chinnaiyan, A.M.¹⁶

5
- 41149121704
- Complex patterns of ETS gene alteration arise during cancer development in the human prostate
- Clark J, Attard G, Jhavar S, et al. Complex patterns of ETS gene alteration arise during cancer development in the human prostate. Oncogene 2008;27:1993-2003.
- (2008) Oncogene , vol.27 , pp. 1993-2003
- Clark, J.¹ Attard, G.² Jhavar, S.³

6
- 34548572763
- Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: Molecular evidence for an independent group of diseases
- DOI 10.1158/0008-5472.CAN-07-2043
- Mehra R, Han B, Tomlins SA, et al. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. Cancer Res 2007;67:7991-7995 (Pubitemid 47395131)
- (2007) Cancer Research , vol.67 , Issue.17 , pp. 7991-7995
- Mehra, R.¹ Han, B.² Tomlins, S.A.³ Wang, L.⁴ Menon, A.⁵ Wasco, M.J.⁶ Shen, R.⁷ Montie, J.E.⁸ Chinnaiyan, A.M.⁹ Shah, R.B.¹⁰

7
- 34447342868
- TMPRSS2-ERG fusion prostate cancer: An early molecular event associated with invasion
- DOI 10.1097/01.pas.0000213424.38503.aa, PII 0000047820070600000008
- Perner S, Mosquera JM, Demichelis F, et al. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol 2007;31:882-888 (Pubitemid 47165141)
- (2007) American Journal of Surgical Pathology , vol.31 , Issue.6 , pp. 882-888
- Perner, S.¹ Mosquera, J.-M.² Demichelis, F.³ Hofer, M.D.⁴ Paris, P.L.⁵ Simko, J.⁶ Collins, C.⁷ Bismar, T.A.⁸ Chinnaiyan, A.M.⁹ De Marzo, A.M.¹⁰ Rubin, M.A.¹¹

8
- 38649092412
- Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer
- Furusato B, Gao CL, Ravindranath L, et al. Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer. Mod Pathol 2008;21:67-75.
- (2008) Mod Pathol , vol.21 , pp. 67-75
- Furusato, B.¹ Gao, C.L.² Ravindranath, L.³

9
- 38049123346
- Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
- Attard G, Clark J, Ambroisine L, et al. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene 2008;27:253-263
- (2008) Oncogene , vol.27 , pp. 253-263
- Attard, G.¹ Clark, J.² Ambroisine, L.³

10
- 53749090666
- Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven
- Attard G, Reid AH, Yap TA, et al. Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven. J Clin Oncol 2008;26:4563-4571
- (2008) J Clin Oncol , vol.26 , pp. 4563-4571
- Attard, G.¹ Reid, A.H.² Yap, T.A.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.